Previous
Next
Dear colleagues,
 
The 16th international Conference of the Society on Cachexia, Sarcopenia & Muscle Wasting, will take place on 17-19 June 2023 in Stockholm, Sweden, under the guidance of Chairs of the SCWD, Professor Stefan Anker (Berlin, Germany) and Professor Gianluigi Savarese (Stockholm, Sweden).
 
To make sure the international community around the world keeps abreast with the latest advancements after the challenging COVID 19 pandemic and the recent events in Eastern Europe, the Board of the SCWD is determined to create the best possible
conditions for the cachexia and sarcopenia community to meet in person.
SCWD will also make sure highlights of the conference are accessible with virtual options to attend remotely via our digital interactive platform.
 
Abstract submission will open on December. Please visit our website regularly for updates.
 
We hope to see you in Stockholm and look forward to working with you again to continue the tradition of a mutually rewarding and intellectually stimulating SCWD conference!
 
Best regards,
Prof. Stefan Anker (President, SCWD) and Gianluigi Savarese

From the literature

Perioperative nutrition and sarcopenic cancer: a review

Perioperative care in cancer patients is being reconsidered with our understanding of the association of sarcopenia and post-operative complications risks. Generally, there exists very little literature regarding the perioperative care of sarcopenic cancer patients. It has, however, been found that sarcopenic patients had significantly higher complication rates than that of non-sarcopenic patients. Future research needs to continue to understand the reasons behind this. Perioperative cancer also needs to be understood within various degrees of sarcopenia, through stratifying the population by muscle depletion and reduced function levels. Although nutritional support alone cannot counteract these issues that sarcopenic patients face, this approach can aid in decreasing progressive muscle mass loss, potentially lowering the risk of post-operative complications.
This review by Bozzetti F aimed to understand the relationship between sarcopenia, muscle mass loss, and nutritional interventions.

Read More »
November 25, 2022

Muscle depleted obesity and colorectal cancer: a review

Colorectal cancer is the second leading cause of cancer death in the world. However, incidence rates and mortality can both be significantly reduced through adhering to healthy lifestyle recommendations. In this study, 82 people were included, where their nutritional profile was evaluated to assess their risk of colorectal cancer. This is because obesity is one of the biggest risk factors for colorectal cancer, and when associated with sarcopenia, there are usually worse health outcomes. This study has therefore highlighted the need for understanding muscle composition in obese individuals when screening for cancer, as this may affect outcomes. Furthermore, this study underscores the necessity to aim for health lifestyles through weight control and physical exercise, to decrease incidence and mortality of diseases such as colorectal cancer.
This review by Santos M et al. aimed to evaluate nutritional profiles for those screening for colorectal cancer, to aid a better understanding of the risk factors behind this cancer.

Read More »
November 24, 2022

Frailty status, inflammatory, and muscle catabolism biomarker patterns: a strong association?

Fraily development is largely determined by low levels of nutrients, increased expression of inflammatory biomarkers, and age-related oxidative stress (OS). These frailty-related dysfunctions may lead to impairments in muscle structure and function, causing the onset of a muscle-catabolic state. As such, they may contribute to the development of sarcopenia, which is both a cause and a consequence of frailty.
Measuring biomarker patterns such as dietary, OS, inflammatory, and muscle-related biomarkers (e.g., 3-methylhistidine (3MH)) has been touted as a means to understand the complex mechanisms behind frailty. Despite this, data on multi-biomarker patterns remains scarce.

The aim of this study was to measure a variety of circulating biomarkers in an attempt to characterise their patterns. The existence of an association between these patterns and frailty status in non-frail and frail in-hospital patients was then assessed.

Read More »
November 24, 2022

The role of sarcopenia-associated mitochondrial dysfunction in recovery post-arthroplasty

Total knee arthroplasty (TKA) is the main procedure used to treat end-stage osteoarthritis. Although it is a highly successful treatment associated with 10-year survival in over 90% of cases, approximately 25% of patients experience unsatisfactory functional outcomes. Poor recovery rates after TKA have been linked to sarcopenia, a condition up to 44% of patients undergoing TKA suffer from.
Mitochondrial dysfunction is one of sarcopenia’s major drivers. Despite this, mitochondrial function’s role in recovery post-TKA remains unknown.

The aim of this study was to investigate the link between mitochondrial function at baseline and recovery after TKA. To do so, activity after TKA was monitored using a wrist mounted tracker. From this data, the relationship between activity and traditional outcome measures (e.g. grip strength) associated with recovery was clarified.

Read More »
November 24, 2022
Reviewed articles

Sitemap

Contact us

Contact us

Follow us

Twitter Facebook

Copyright © 2009 – 2022 Society on Sarcopenia, Cachexia and Wasting Disorders. All Rights Reserved. Data Privacy

Consent Management Platform by Real Cookie Banner